Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
Descrição
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label
Statins for Graves' orbitopathy: a new tool for prevention and
Statin use before diabetes diagnosis and risk of microvascular
Current and Emerging Treatment Strategies for Graves' Orbitopathy
Current concepts regarding Graves' orbitopathy - Bartalena - 2022
Adverse events associated with unblinded, but not with blinded
Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO
Proposal for Standardization of Primary and Secondary Outcomes in
Lancet子刊：万能药他汀又来了，甲亢突眼它也能治！@MedSci
Effect of dapagliflozin on the rate of decline in kidney function
Management of Thyroid Eye Disease: A Consensus Statement by the
Traditional Chinese medicine in thyroid-associated orbitopathy
de
por adulto (o preço varia de acordo com o tamanho do grupo)
